Please see full Prescribing Information for AREXVY. About SHINGRIX (Recombinant ZosterVaccine or RZV) SHINGRIX is a non-live, recombinant subunit vaccine indicated for the prevention of ...
The Advisory Committee on Immunization Practices (ACIP) recommends a single dose of zostervaccine for immunocompetent adults 60 years of age and older, based on the results of this study ...
Among the 461,323 individuals who received at least 1 RZV dose, 1264 experienced new-onset gout within 60 days postvaccination; 302 patients were determined to have incident cases of gout, with no ...
Some results have been hidden because they may be inaccessible to you